All In Biotech

Free tool

FAERS Monitor: Contrave

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 200063 or its brand name (Contrave, Bupropion Hydrochloride, Naltrexone Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

8,503

Serious

2,837

33% of reports

Hospitalization

562

Death reported

30

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea1,989
  • headache1,116
  • dizziness1,051
  • vomiting680
  • constipation648
  • feeling abnormal583
  • fatigue526
  • anxiety406
  • insomnia396
  • diarrhoea374
  • drug ineffective368
  • patient dissatisfaction with treatment344
  • tremor337
  • drug titration error333
  • illness332

Reports by year received

View as table
YearReports
201413
20151,572
2016832
2017210
2018243
2019308
2020439
2021276
2022355
2023432
20241,327
20252,412
202684

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,656 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
patient dissatisfaction with treatmentSignal344537.2479.0150,845
drug titration errorSignal333366.1327.0105,331
illnessSignal3328.07.22,028
constipationSignal6487.46.83,587
nauseaSignal1,9896.26.09,045
feeling abnormalSignal5836.05.62,463
dizzinessSignal1,0515.24.93,662
tremorSignal3375.04.51,091
headacheSignal1,1164.44.23,023
insomniaSignal3963.73.3780
vomitingSignal6803.63.31,290
anxietySignal4063.53.2744
fatigue5261.71.5147
diarrhoea3741.41.350
drug ineffective3680.70.654

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.